Selective stimulation of serotonin2Creceptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration
- 22 March 2004
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 89 (2) , 418-429
- https://doi.org/10.1111/j.1471-4159.2004.02337.x
Abstract
The effects of acute and repeated nicotine administration on the extracellular levels of dopamine (DA) in the corpus striatum and the nucleus accumbens were studied in conscious, freely moving rats byin vivomicrodialysis. Acute intraperitoneal (i.p.) injection of nicotine (1 mg/kg) increased DA outflow both in the corpus striatum and the nucleus accumbens. Repeated daily injection of nicotine (1 mg/kg, i.p.) for 10 consecutive days caused a significant increase in basal DA outflow both in the corpus striatum and the nucleus accumbens. Acute challenge with nicotine (1 mg/kg, i.p.) in animals treated repeatedly with this drug enhanced DA extracellular levels in both brain areas. However, the effect of nicotine was potentiated in the nucleus accumbens, but not in the corpus striatum. To test the hypothesis that stimulation of 5‐HT (5‐hydroxytryptamine, serotonin)2Creceptors could affect nicotine‐induced DA release, the selective 5‐HT2Creceptor agonist RO 60–0175 was used. Pretreatment with RO 60–0175 (1 and 3 mg/kg, i.p.) dose‐dependently prevented the enhancement in DA release elicited by acute nicotine in the corpus striatum, but was devoid of any significant effect in the nucleus accumbens. RO 60–0175 (1 and 3 mg/kg, i.p.) dose‐dependently reduced the stimulatory effect on striatal and accumbal DA release induced by an acute challenge with nicotine (1 mg/kg, i.p.) in rats treated repeatedly with this alkaloid. However, only the effect of 3 mg/kg RO 60–0175 reached statistical significance. The inhibitory effect of RO 60–0175 on DA release induced by nicotine in the corpus striatum and the nucleus accumbens was completely prevented by SB 242084 (0.5 mg/kg, i.p.) and SB 243213 (0.5 mg/kg, i.p.), two selective antagonists of 5‐HT2Creceptors. It is concluded that selective activation of 5‐HT2Creceptors can block the stimulatory action of nicotine on central DA function, an effect that might be relevant for the reported antiaddictive properties of RO 60–0175.Keywords
This publication has 90 references indexed in Scilit:
- Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental areaMolecular Psychiatry, 2003
- Involvement of α7 Nicotinic Acetylcholine Receptors in Gene Expression of Dopamine Biosynthetic Enzymes in Rat BrainThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugsNature, 1996
- Molecular and Cellular Aspects of Nicotine AbusePublished by Elsevier ,1996
- Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate NeuronsAnnual Review of Physiology, 1995
- Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate NeuronsAnnual Review of Physiology, 1995
- Desensitization of Nicotine‐Stimulated [3H]Dopamine Release from Mouse Striatal SynaptosomesJournal of Neurochemistry, 1994
- Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental areaSynapse, 1994
- Effects of systemic nicotine on serotonin release in rat brainBrain Research, 1993
- The Diversity of Neuronal Nicotinic Acetylcholine ReceptorsAnnual Review of Neuroscience, 1993